<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04707638</url>
  </required_header>
  <id_info>
    <org_study_id>NS20201230</org_study_id>
    <nct_id>NCT04707638</nct_id>
  </id_info>
  <brief_title>Neurophysiological Characteristics of Subthalamic Deep-brain Stimulation (STN-DBS)</brief_title>
  <official_title>Neurophysiological Characteristics of Subthalamic Deep-brain Stimulation (STN-DBS) Under General Anesthesia for Patients With Parkinson's Disease or Dystonia and Their Correlation With Prognosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wuhan Union Hospital, China</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intraoperative neuroelectrophysiological signals were collected from patients undergoing&#xD;
      STN-DBS under general anesthesia in the Neurosurgery Department of Wuhan union Hospital, and&#xD;
      their preoperative conditions and postoperative efficacy will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The intraoperative neuroelectrophysiological signals were collected from patients undergoing&#xD;
      STN-DBS under general anesthesia in the Neurosurgery Department of Wuhan union Hospital, and&#xD;
      their preoperative conditions and postoperative efficacy will be evaluated. The&#xD;
      intraoperative neuroelectrophysiological signals would be analyzed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Ethics application has not been completed yet&#xD;
  </why_stopped>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">January 11, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 11, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Unified Parkinson's Disease Rating Scale (UPDRS)</measure>
    <time_frame>Two years postoperatively</time_frame>
    <description>UPDRS has four parts: part I (nonmotor experiences of daily living, total score=16); part II (patient motor experience of daily living, total score=52); part III (clinician motor examination, total score=56); part IV (complications, total score=23). The total score of all the four parts is147. Higher scores means a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Burke Fahn Marsden's Dystonia Rating Scales(BFMDRS)</measure>
    <time_frame>Two years postoperatively</time_frame>
    <description>BFMDRS has two parts: BFMDRS movement part (BFMDRS-M) and BFMDRS disability part (BFMDRS-D). The total score of BFMDRS-M is 120 and the total score of BFMDRS-D is 30. Higher scores means a worse outcome.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Dystonia</condition>
  <arm_group>
    <arm_group_label>Parkinson's disease or dystonia patients</arm_group_label>
    <description>Patients with Parkinson's disease or dystonia and underwent STN DBS under general anesthesia in neurosurgery department</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention used</intervention_name>
    <description>No intervention used</description>
    <arm_group_label>Parkinson's disease or dystonia patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Parkinson's disease or dystonia and STN-DBS in neurosurgery department of&#xD;
        Wuhan Union Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients underwentSTN-DBS in neurosurgery department of Wuhan Union Hospital.&#xD;
&#xD;
          2. Patients with Parkinson's disease or dystonia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1.Patients without enough follow-up length.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fu Peng, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neurosurgery department of Wuhan Union Hospital</affiliation>
  </overall_official>
  <reference>
    <citation>Tsai ST, Kuo CC, Chen TY, Chen SY. Neurophysiological comparisons of subthalamic deep-brain stimulation for Parkinson's disease between patients receiving general and local anesthesia. Ci Ji Yi Xue Za Zhi. 2016 Apr-Jun;28(2):63-67. doi: 10.1016/j.tcmj.2016.02.003. Epub 2016 Apr 10.</citation>
    <PMID>28757724</PMID>
  </reference>
  <reference>
    <citation>Yamada K, Goto S, Kuratsu J, Matsuzaki K, Tamura T, Nagahiro S, Murase N, Shimazu H, Kaji R. Stereotactic surgery for subthalamic nucleus stimulation under general anesthesia: a retrospective evaluation of Japanese patients with Parkinson's disease. Parkinsonism Relat Disord. 2007 Mar;13(2):101-7. Epub 2006 Oct 19.</citation>
    <PMID>17055325</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 11, 2021</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2021</study_first_posted>
  <last_update_submitted>January 31, 2021</last_update_submitted>
  <last_update_submitted_qc>January 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parkinson Disease</keyword>
  <keyword>Dystonia</keyword>
  <keyword>deep brain stimultation</keyword>
  <keyword>neurophysiological characteristics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Dystonic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

